CME/CE

Endocrinology CME/CE Courses

myCMEYour search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Featured Courses

Critical Impact of Inflammation in Lysosomal Diseases: Unlocking Future Treatments and Improving Outcomes

Critical Impact of Inflammation in Lysosomal Diseases: Unlocking Future Treatments and Improving Outcomes | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s)
The goal of this activity, which was held at WORLDSymposium 2021 will be to address the critical role of inflammation in lysosomal diseases, with a specific focus on inflammation in Gaucher disease, mucopolysaccharidosis type II (MPS II), and metachromatic leukodystrophy (MLD). Gaucher disease, MPS II, and MLD are three lysosomal diseases in which inflammation plays a significant role in disease progression and associated neurodegeneration.
AACE Advanced Technology for Diabetes Care

AACE Advanced Technology for Diabetes Care | myCME

AMA PRA Category 1 Credit(s)TM, ABIM MOC Credit, ANCC Contact Hour(s), CE for Pharmacists, AAPA Category I CME credit
Two video-based, pre-recorded webinars with presenters who are experts in the field will cover the following topics: Exploring CGM, Identifying Patients Who Will Benefit from CGM , and Emerging Technologies: A Better Life for Patients with Diabetes
Preventing Cardiovascular Events in High-Risk Diabetes Patients with CAD

Preventing Cardiovascular Events in High-Risk Diabetes Patients with CAD | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists, CPEU Credit
Diabetes increases the risk of cardiovascular and thrombotic adverse events in patients with CAD compared to patients with these conditions and no concomitant diabetes. This virtual symposium will review several recently-completed and ongoing clinical trials evaluating the efficacy and safety of current antiplatelet therapy to prevent adverse events in these high-risk patients, including the use of more aggressive and specific antithrombotic agents in this setting.
HIV with Comorbid Conditions: Managing the Metabolic Syndrome, Diabetes and Cardiovascular Disease in Older Patients Living with HIV

HIV with Comorbid Conditions | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), AAPA Category I CME credit, CE for Pharmacists
Experts in the management of patients living with HIV discuss issues currently of particular significance including the effect of aging and associated HIV-related comorbidities, the increasingly important role of primary care providers, and the effect of COVID-19. Emphasis will be placed on the metabolic syndrome and its effect on HIV management.
Moving Beyond Diabetes: Managing the Cardiometabolic Profile – A Virtual Patient Simulation

Beyond Diabetes: The Cardiometabolic Profile – Virtual Simulation | myCME

AMA PRA Category 1 Credit(s)TM, NCPD Contact Hour(s)
In this AI-based virtual patient simulation (VPS) series, you will meet two unique patients with diabetes and cardiovascular risk who will test your ability to assess their condition and personalize their treatment. The simulation platform allows for real-world clinical decision-making in a risk-free learning environment.
Hereditary Pheochromocytoma and Paraganglioma: Strategies for Screening and Surveillance

Hereditary Pheochromocytoma and Paraganglioma

AMA PRA Category 1 Credit(s)TM
The goal of this activity is to provide clinicians with a brief review of hereditary paraganglioma-pheochromocytoma syndrome, SDHD-Associated tumor risks, and surveillance recommendations.
Pediatric GHD: Working Together To Ensure Success

Pediatric GHD: Working Together To Ensure Success

AMA PRA Category 1 Credit(s)TM
The Endocrine Society and The France Foundation is providing this enduring material for any pediatric and general endocrinologist, family physician, pediatrician, nurse practitioner, or physician assistant who is interested in learning more about pediatric GHD and its management.
100 Years of Innovation in Insulin Therapy

100 Years of Innovation in Insulin Therapy

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s)
This program is designed to review key advances in insulin therapy from its introduction in the early 1920s to current innovations.

Click for More Endocrinology Courses

Next hm-section-front in CME